Vascular endothelial growth factors in cardiovascular medicine.
The discovery of vascular endothelial growth factors (VEGFs) and their receptors has considerably improved the understanding of the development and function of endothelial cells. Each member of the VEGF family appears to have a specific function: VEGF-A induces angiogenesis (i.e. growth of new blood vessels from preexisting ones), placental growth factor mediates both angiogenesis and arteriogenesis (i.e. the formation of collateral arteries from preexisting arterioles), VEGF-C and VEGF-D act mainly as lymphangiogenic factors. The study of the biology of these endothelial growth factors has allowed a major progress in the comprehension of the genesis of the vascular system and its abnormalities observed in various pathologic conditions (atherosclerosis and coronary artery disease). The role of VEGF in the atherogenic process is still unclear, but actual evidence suggests both detrimental (development of a neoangiogenetic process within the atherosclerotic plaque) and beneficial (promotion of collateral vessel formation) effects. VEGF and other angiogenic growth factors (fibroblast growth factor), although initially promising in experimental studies and in initial phase I/II clinical trials in patients with ischemic heart disease or peripheral arterial occlusive disease, have subsequently failed to show significant therapeutic improvements in controlled clinical studies. Challenges still remain about the type or the combination of angiogenic factors to be administered, the form (protein vs. gene), the route, and the duration of administration.
Testa
Ugo
U
Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Italy. ugo.testa@iss.it
Pannitteri
Gaetano
G
Condorelli
Gian Luigi
GL
D002318:Cardiovascular Diseases / Q000503:physiopathology; D042783:Endothelial Cells / Q000502:physiology; D006801:Humans; D008565:Membrane Proteins / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology* / Q000627:therapeutic use; D042561:Vascular Endothelial Growth Factor B / Q000502:physiology; D042582:Vascular Endothelial Growth Factor C / Q000502:physiology; D042643:Vascular Endothelial Growth Factor D / Q000502:physiology
D008565:Membrane Proteins; C098069:PIGF protein, human; D042461:Vascular Endothelial Growth Factor A; D042561:Vascular Endothelial Growth Factor B; D042582:Vascular Endothelial Growth Factor C; D042643:Vascular Endothelial Growth Factor D